Luca Steardo Selected Research

Aftercare (After-Treatment)

1/2021

Naturalistic and Uncontrolled Pilot Study on the Efficacy of Vortioxetine in Binge Eating Disorder With Comorbid Depression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Steardo Research Topics

Disease

19	Alzheimer Disease (Alzheimer's Disease) 05/2022 - 01/2002
12	Inflammation (Inflammations) 05/2022 - 01/2008
12	Gliosis 05/2022 - 09/2007
10	Neuroinflammatory Diseases 03/2024 - 01/2011
7	Mental Disorders (Mental Disorder) 07/2023 - 01/2016
7	Bipolar Disorder (Manic Depressive Psychosis) 09/2022 - 01/2019
6	Schizophrenia (Dementia Praecox) 03/2023 - 03/2014
5	Colitis 01/2022 - 12/2012
5	Body Weight (Weight, Body) 01/2021 - 01/2002
4	Alcoholism (Alcohol Abuse) 01/2015 - 05/2009
3	Sleep Wake Disorders 03/2024 - 12/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2013 - 01/2009
2	Disease Progression 03/2023 - 02/2021
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2016
2	Pain (Aches) 01/2022 - 03/2021
2	COVID-19 09/2021 - 01/2020
2	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2021 - 01/2020
2	Bulimia (Binge Eating) 01/2021 - 07/2014
2	Food Addiction 01/2021 - 09/2012
2	Diarrhea 03/2018 - 10/2017
2	Anorexia Nervosa 01/2018 - 09/2011
2	Obesity 09/2015 - 11/2013
2	Neoplasms (Cancer) 06/2015 - 01/2015
2	Glioma (Gliomas) 06/2015 - 09/2006
2	Astrocytoma (Pilocytic Astrocytoma) 01/2015 - 09/2007
2	Anorexia 11/2013 - 05/2007
2	Cognitive Dysfunction 09/2007 - 01/2002
1	Wounds and Injuries (Trauma) 03/2024
1	Mania (Manias) 03/2023
1	Anxiety Disorders (Anxiety Disorder) 01/2023
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023
1	Antisocial Personality Disorder (Antisocial Personality) 02/2021
1	Binge-Eating Disorder (Binge Eating Disorder) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Major Depressive Disorder (Major Depressive Disorders) 01/2020
1	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Insulin Resistance 01/2019

Drug/Important Bio-Agent (IBA)

13	palmidrolIBA 05/2022 - 12/2011
13	Proteins (Proteins, Gene)FDA Link 01/2019 - 09/2006
9	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 05/2022 - 01/2011
6	CannabidiolIBA 03/2024 - 01/2009
5	Amyloid beta-PeptidesIBA 05/2022 - 09/2006
5	Amyloid (Amyloid Fibrils)IBA 11/2019 - 12/2011
4	CannabinoidsIBA 03/2024 - 09/2007
4	CalciumIBA 01/2023 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2020
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2022 - 12/2010
3	Neurotransmitter Agents (Neurotransmitter)IBA 03/2021 - 01/2002
3	NF-kappa B (NF-kB)IBA 03/2018 - 08/2014
3	Nerve Growth Factors (Neurotrophins)IBA 01/2017 - 01/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2016 - 12/2010
3	Dextrans (Dextran)FDA Link 01/2016 - 12/2012
3	SodiumIBA 01/2016 - 12/2012
3	Pentamidine (NebuPent)FDA LinkGeneric 06/2015 - 12/2012
3	Ethanol (Ethyl Alcohol)IBA 01/2015 - 05/2009
2	Dronabinol (THC)FDA LinkGeneric 03/2024 - 03/2014
2	Antipsychotic Agents (Antipsychotics)IBA 03/2023 - 07/2021
2	LuteolinIBA 05/2022 - 05/2020
2	LithiumIBA 07/2020 - 01/2019
2	CytokinesIBA 05/2020 - 01/2011
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 01/2015
2	PPAR alphaIBA 03/2018 - 01/2016
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2018 - 09/2011
2	Neuroprotective AgentsIBA 01/2018 - 03/2012
2	Glutamic Acid (Glutamate)FDA Link 01/2017 - 01/2016
2	Sigma-1 ReceptorIBA 01/2016 - 01/2015
2	Glial Fibrillary Acidic ProteinIBA 01/2015 - 09/2007
2	Peptides (Polypeptides)IBA 12/2011 - 09/2006
2	GABA-A Receptors (GABA(A) Receptor)IBA 09/2007 - 05/2007
1	SDMIBA 07/2023
1	Antidepressive Agents (Antidepressants)IBA 03/2023
1	Tight Junction ProteinsIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Glucosamine (Dona)IBA 01/2022
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2022
1	Prostaglandins AIBA 01/2022
1	LipidsIBA 09/2021
1	EndocannabinoidsIBA 03/2021
1	Hormones (Hormone)IBA 03/2021
1	nabilone (Cesamet)FDA Link 03/2021
1	4-aminospiroperidolIBA 02/2021
1	VortioxetineIBA 01/2021
1	BESIBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2020
1	Messenger RNA (mRNA)IBA 05/2020
1	EnzymesIBA 05/2020
1	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 05/2020
1	Chemokine ReceptorsIBA 11/2019
1	ChemokinesIBA 11/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2019
1	PotassiumIBA 01/2019
1	tat Gene Products (tat Protein)IBA 03/2018
1	AntidiarrhealsIBA 03/2018
1	Trans-Activators (Trans-Acting Factor)IBA 03/2018

Therapy/Procedure

10	Therapeutics 03/2024 - 01/2009
2	Injections 03/2023 - 07/2021
1	Treatment Delay 10/2021
1	Aftercare (After-Treatment) 01/2021
1	Phototherapy (Light Therapy) 12/2018